The Heart Rhythm Society this week released its guidelines on device lead management and extraction for implantable cardiovascular electronic devices.
The new guidelines are the result of a collaboration amongst 10 international organizations, according to the HRS.
Included contributing organizations are the HRS, American College of Cardiology, American Heart Association, Asia Pacific Heart Rhythm Society, American Society of Anesthesiologists, European Heart Rhythm Association, Infectious Diseases Society of America, Latin American Hearth Rhythm Society, Pediatric and Congenital Electrophysiology Society and the Society of Thoracic Surgeons, the HRS reports.
The document specifically focuses on recommendations around lead survival, managing existing CIED leads, infectious and noninfectious indications for lead extraction and outcomes and follow-ups.
The updated guidance is built off of guidelines released in 2009, the HRS said, which provided “detailed recommendations on facilities and training for lead extraction that remain appropriate.”
The HRS said that 18 of 29 committee members who contributed to the revised guidelines were from individuals who had verifiably less than $10,000 worth in financial relationships within the industry.
Visit https://cloudysocial.com for more.
In June 2015, a number of cardiac medical societies updated their guidelines for stroke treatment to take into account new devices and technology, including left atrial appendage occlusion devices, stent retrievers and thrombectomy devices.